ASEP Medical Holdings Inc (TSE:ASEP) has released an update.
ASEP Medical Holdings Inc. announces that its joint venture, SepSMART, has successfully acquired its business license and completed formal registration in China, a key step in finalizing their partnership with Sansure Biotech Inc. This milestone allows for the issuance of 3 million performance warrants to Sansure, enabling further progress in commercializing ASEP’s innovative diagnostic and therapeutic technologies in the Chinese market.
For further insights into TSE:ASEP stock, check out TipRanks’ Stock Analysis page.